Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device has supplements. The device description may have changed. Be sure to look at the supplements to get an up-to-date view of this device.
 
Trade NameCOMBI 40+ COCHLEAR IMPLANT SYSTEM
Classification Nameimplant, cochlear
Generic Namecochlear implant system
ApplicantMED-EL CORP.
PMA NumberP000025
Date Received06/29/2000
Decision Date08/20/2001
Product Code
MCM[ Registered Establishments with MCM ]
Docket Number 02M-0006
Notice Date 01/11/2002
Advisory Committee Ear Nose & Throat
Expedited Review Granted? No
Combination Product No
Information About: Labeling, Approval Order, Summary of Safety and Effectiveness
Approval Order Statement 
Approval for the med-el combi 40+ cochlear implant system (combi 40+). The device is intended to provide the opportunity to detect and recognize auditory information through electrical stimulation of the auditory nerve for server to profoundly hearing-impaired individuals who obtain little or no benefit from conventional acoustic amplification in the best-aided condition. The combi 40+ is indicated for the following patient populations: adults of eighteen (18) years of age or older who have bilateral, sensorineural hearing impairment and obtain limited benefit from appropriately fitted binaural hearing aids. These individuals typically demonstrate bilateral severe to profound sensorineural hearing loss determined by a pure tone average of 70 db or greater at 500 hz, 1000 hz, and 2000 hz. Limited benefit from amplification is defined by test scores of 40% correct or less in best-aided listening condition on cd recorded tests of open-set sentence recognition hearing in noise test (hint) sentences. Children aged eighteen (18) months to seventeen (17) years eleven (11) months must demonstrate a profound, bilateral sensorineural hearing loss with thresholds of 90 db or greater at 1000hz. In younger children, little or no benefit is defined by lack of progress in the development of simple auditory skills in conjunction with appropriate amplification and participation in intensive aural habilitation over a three (3) to six (6) month period. In older children, lack of aided benefit is defined as < 20% correct on the multi-syllabic lexical neighborhood test (mlnt) or lexical neighborhood test (lnt), depending upon the child's cognitive ability and linguistic skills. A three (3) to six (6) month hearing aid trial is required for children without previous experience with hearing aids. Radiological evidence of cochlear ossification may justify a shorter trial with amplification.
Approval Order Approval Order
Supplements: S001 S002 S003 S004 S005 S006 
S007 S008 S009 S010 S011 S012 
S013 S014 S017 S018 S019 S020 
S021 S023 S024 S025 S026 S027 
S028 S029 S031 S032 S033 S034 
S035 S036 S037 S038 S039 S040 
S041 S042 S043 S044 S045 S046 
S047 S048 S049 S050 S051 S052 
S053 S054 S055 S056 S057 S058 
S059 S060 S061 S062 S064 S065 
S066 S068 
-
-